Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)
CUSIP: 45782T105
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 27,969,231
- Total 13F shares
- 358,561
- Share change
- +15,448
- Total reported value
- $1,881,000
- Price per share
- $5.17
- Number of holders
- 11
- Value change
- +$104,639
- Number of buys
- 5
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 45782T105?
CUSIP 45782T105 identifies INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45782T105:
Top shareholders of INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Financial Advocates Investment Management |
13F
|
Company |
0.91%
|
253,461
|
$844,000 | — | 31 Mar 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.2%
|
56,048
|
$187,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.06%
|
15,752
|
$52,000 | — | 31 Mar 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
11,443
|
$38,000 | — | 31 Mar 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
1,700
|
$6,000 | — | 31 Mar 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,079
|
$4,000 | — | 31 Mar 2020 | |
| Covington Capital Management |
13F
|
Company |
0%
|
1,000
|
$3,000 | — | 31 Mar 2020 | |
| TRUE Private Wealth Advisors |
13F
|
Company |
0%
|
1,000
|
$3,000 | — | 31 Mar 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0%
|
730
|
$2,000 | — | 31 Mar 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
200
|
$1,000 | — | 31 Mar 2020 |
Institutional Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) as of Q2 2020
As of 30 Jun 2020,
Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
358,561 shares.
The largest 10 holders included
Financial Advocates Investment Management, DEUTSCHE BANK AG\, BlackRock Inc., BANK OF AMERICA CORP /DE/, Tower Research Capital LLC (TRC), FNY Investment Advisers, LLC, Covington Capital Management, TRUE Private Wealth Advisors, UBS Group AG, and Private Advisor Group, LLC.
This page lists
11
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
9
Q2 2020 holders
11
Holder diff
2
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.